Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/5/16 → 07/19/18 |
Funding
- Eisai Incorporated: $10,746.00
A Randomized, Open-Label, Multicenter, Phase 1b/2 Study of Eribulin Mesylate in Combination with PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects with Human Epidermal Growth Factor Receptor 2...
- Stopeck, Alison (PI)
- Baer, Lea (CoPI)
- Cohen, Jules A (CoPI)
Project: Research